In conclusion, hypoxia-induced downregulation of TRIM21 stabilizes ID1 and promotes pancreatic tumor progression, highlighting the TRIM21–ID1 pathway as a promising therapeutic target for pancreatic adenocarcinoma. This evidence concerns the gene TRIM21 and pancreatic neoplasm.